Tickerplace logo

Tickerplace

Repligen Corporation logo

RGENRepligen Corporation

RGEN Stock Price, Valuation & Chart | Repligen Corporation

Compare
$175.42-8.75 (-4.75%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Instruments & Supplies
OverviewFinancialsDividendsRatios

RGEN Historical price chart

RGEN Key Stats

Market Capitalization11.14B
PE Ratio97.46
EPS1.8
Trading Volume1.21M
Today's High/Low185.34/172.4
Dividend Yield0.00
52 Week High/Low198.87/100.99
Shares Outstanding63.49M
RGEN Financial Statement
RGEN Analyst ratings
RGEN Analysis & performance metrics

RGEN Company profile

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia…

RGEN Management team

Management
Neil Whitfield
Senior Vice President of Sales
Keith Lee RobinsonCTO
Chief Information Officer
Anthony J. Hunt
Executive Chair
Ralf Kuriyel
Senior Vice President of Research & Development
Jason K. GarlandCFO
Chief Financial Officer & Chief Compliance Officer
James R. BylundCOO
Chief Operating Officer
Olivier LoeillotCEO
President, Chief Executive Officer & Director
Sondra S. Newman
Global Head of Investor Relations
Total 8 executives

RGEN Frequently asked questions

What is Repligen Corporation (RGEN) Stock Price?

Current stock price of Repligen Corporation (RGEN) stock is $175.42. The stock price is -4.75% lower in the session. The intraday range can be seen from this page. Volume of Repligen Corporation (RGEN) stock is 1.21M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Repligen Corporation (RGEN) stock price going up or down today?

The stock price of Repligen Corporation (RGEN) can change with earnings, company news, and overall market sentiment. Repligen Corporation operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Repligen Corporation stock expensive at its current price?

Whether Repligen Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RGEN on this page is 97.46. EPS on this page is 1.80. Compare those figures with peers and growth expectations before deciding if the current Repligen Corporation price is justified.

How has the stock price of Repligen Corporation (RGEN) performed historically?

Historical performance for Repligen Corporation (RGEN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RGEN reacted to past earnings and market events.

Should I buy Repligen Corporation (RGEN) stock, at this price?

Buying Repligen Corporation (RGEN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.